Side-by-side comparison
NVO vs AMGN — Side-by-side comparison
AMGN screens cheaper on EV/FCF, AMGN has the higher ROIC, AMGN has grown revenue faster over five years, and AMGN has the cleaner balance sheet by net debt / EBITDA.
NVO
Novo Nordisk A S
Price
$44.96
Market cap
$305.8B
Day %
N/A
AMGN
Amgen
Price
$339.30
Market cap
$150.6B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
NVO implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
AMGN implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
24.2x
FCF yield
5.4%
5Y rev CAGR
7.6%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for NVO.
Grade F
0
/ 100
Quality Scorecard
Build-time composite score for AMGN.
Grade C
56
/ 100